MergerLinks Header Logo

Request Deal Involvement

EQRx went public via a SPAC merger with CM Life Sciences III in a $3.6bn deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

1AB

pr advisors

1AB

JP Morgan

financial advisors

JP Morgan

Goldman Sachs

financial advisors

Goldman Sachs

Goodwin Procter

legal advisors

Goodwin Procter

PJT Partners

financial advisors

PJT Partners

TD Cowen

financial advisors

TD Cowen

Jefferies & Company

financial advisors

Jefferies & Company

White & Case

legal advisors

White & Case

JP Morgan

financial advisors

JP Morgan

Houlihan Lokey

financial advisors

Houlihan Lokey

Alston & Bird

legal advisors to financial advisors

Alston & Bird

or

Principals

BVF PARTNERS

bidder

BVF PARTNERS

SOFTBANK GROUP CORP

bidder

SOFTBANK GROUP CORP

BAIN CAPITAL LP

bidder

BAIN CAPITAL LP

ROCK SPRINGS CAPITAL

bidder

ROCK SPRINGS CAPITAL

VERILY LIFE SCIENCES LLC

bidder

VERILY LIFE SCIENCES LLC

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

EQRX

target

EQRX

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

bidder

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

MUBADALA INVESTMENT COMPANY

bidder

MUBADALA INVESTMENT COMPANY

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

AVIDITY PARTNERS

bidder

AVIDITY PARTNERS

CASDIN CAPITAL

bidder

CASDIN CAPITAL

CM LIFE SCIENCES III

bidder

CM LIFE SCIENCES III

CORVEX MANAGEMENT

bidder

CORVEX MANAGEMENT

BOXER CAPITAL

bidder

BOXER CAPITAL

ANDREESSEN HOROWITZ LLC (A16Z)

bidder

ANDREESSEN HOROWITZ LLC (A16Z)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite